Suven Nishtaa Pharma has now become a wholly owned subsidiary of Suven Life Sciences. The company’s board of directors at its meeting held on January 31, 2012, have given consent for the amalgamation of the wholly owned subsidiary - Suven Nishtaa Pharma with the holding Company - Suven Life Sciences, subject to the approval of the scheme by the Honble High court of Andhra Pradesh (AP).
Consequent to the merger, there would be no issue of shares to the merger, since the company which is being proposed to be merged with the holding Company is a wholly owned subsidiary.
Suven Life Sciences is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: